Described herein are pharmaceutical packaging devices which reduce oxidative degradation of morphine, hydromorphone, promethazine and other oxygen-sensitive medicines, these types of units such as a syringe with an oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging with quite reduced permeability to oxygen and c